Human NTRK1/MTC/p140-TrkA ORF/cDNA clone-Lentivirus particle (NM_002529)
Cat. No.: vGMLV000283
Pre-made Human NTRK1/MTC/p140-TrkA Lentiviral expression plasmid for NTRK1 lentivirus packaging, NTRK1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
TrkA/NTRK1/MTC products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLV000283 | Human NTRK1 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLV000283 |
Gene Name | NTRK1 |
Accession Number | NM_002529 |
Gene ID | 4914 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 2391 bp |
Gene Alias | MTC,p140-TrkA,TRK,Trk-A,TRK1,TRKA |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
Sequence | 正确 |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T07173-Ab | Anti-NTRK1/ TrkA/ MTC monoclonal antibody |
Target Antigen | GM-Tg-g-T07173-Ag | TrkA/NTRK1 VLP (virus-like particle) |
ORF Viral Vector | pGMLP005346 | Human NTRK1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000283 | Human NTRK1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000500 | Human NTRK1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000501 | Human NTRK1 Lentivirus plasmid |
ORF Viral Vector | vGMLP005346 | Human NTRK1 Lentivirus particle |
ORF Viral Vector | vGMLV000283 | Human NTRK1 Lentivirus particle |
ORF Viral Vector | vGMLV000500 | Human NTRK1 Lentivirus particle |
ORF Viral Vector | vGMLV000501 | Human NTRK1 Lentivirus particle |
Target information
Target ID | GM-T07173 |
Target Name | TrkA |
Gene ID | 4914, 18211, 719670, 59109, 101081603, 490404, 353111, 100064594 |
Gene Symbol and Synonyms | MTC,NTRK1,p140-TrkA,Tkr,TRK,Trk-A,TRK1,TRKA |
Uniprot Accession | P04629 |
Uniprot Entry Name | NTRK1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000198400 |
Target Classification | Kinase, Tumor-associated antigen (TAA) |
This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.